Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: uniQure N.V., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Dianthus Therapeutics Inc. May 22, 202587.9%
-
Rallybio Corporation May 13, 202588.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 16, 2026 | Rallybio Corporation | Option exercise | +3,562 | $2.38 | $8,478 |
| May 8, 2026 | Dianthus Therapeutics Inc. | Option exercise | +599 | $8.44 | $5,056 |
| May 8, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −599 | $85.47 | $51,197 |
| Mar 31, 2026 | Dianthus Therapeutics Inc. | Option exercise | +599 | $8.44 | $5,056 |
| Mar 31, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −599 | $80.11 | $47,986 |
| Mar 24, 2026 | Dianthus Therapeutics Inc. | Option exercise | +27,594 | $8.44 | $232,893 |
| Mar 24, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −27,594 | $78.05 | $2,153,712 |
| Jun 13, 2024 | uniQure N.V. | Open-market sale | −2,220 | $5.14 | $11,411 |
| Jun 16, 2023 | uniQure N.V. | Open-market sale | −2,275 | $18.99 | $43,202 |
| Jun 13, 2023 | uniQure N.V. | Grant or award | +8,700 | — | — |
| Feb 27, 2023 | uniQure N.V. | Open-market sale | −384 | $19.97 | $7,668 |
| Jan 18, 2023 | uniQure N.V. | Option exercise | +6,000 | $5.37 | $32,220 |
| Jan 18, 2023 | uniQure N.V. | Open-market sale | −6,000 | $22.59 | $135,540 |
Questions about Paula Soteropoulos
What boards is Paula Soteropoulos on?
Paula Soteropoulos sits on the boards of Dianthus Therapeutics Inc., Rallybio Corporation and uniQure N.V.
How long has Paula Soteropoulos served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.